A. Corrias et al., GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli, J ENDOC INV, 23(2), 2000, pp. 84-89
Basal IGF-I levels and the GH response to at least two among provocative st
imuli such as clonidine (CLO, Catapresan, 150 mcg/m(2) po), GHRH (1 mcg/kg
iv)+arginine (ARG, 0.5 g/kg iv infusion during 30 min) and GHRH+pyridostigm
ine (PD, Mestinon cpr 60 mg po) have been evaluated in 43 children with Pra
der-Willi syndrome (PWS, 17 males and 26 females, age 3-22 yr, 7 normal wei
ght and 36 obese PWS), in 25 normal short children (NC, 17 mates and 8 fema
les, 7.7-18.5 yr) and in 24 children with simple obesity (OB, 14 males, 10
females, 7.7-21.5 yr). Both normal weight and obese PWS had mean IGF-I leve
ls lower than those recorded in NC (p<0.001) and OB (p<0.001). The GH respo
nses to GHRH+ARG and GHRH+PD in NC were similar and higher than that to CLO
(p<0.001). In PWS the GH response to GHRH+ARC was higher than that to GHRH
+PD (p<0.001) which, in turn, was higher than that to CLO (p<0.001); these
responses in PWS were lower than those in normal children (p<0.02) and simi
lar to those in OB. In normal weight PWS the GH responses to GHRH+ARG and t
o GHRH+PD were similar and higher than to CLO (p<0.05); however, each provo
cative stimulus elicited a GH rise lower than that in NC (p<0.05). In obese
PWS as well as in OB the GH response to GHRH+ARG was higher than that to G
HRH+PD (p<0.02) which, in turn, was higher than that to CLO (p<0.001); all
GH responses in obese PWS and OB were lower than those in NC (p<0.001) but
similar to those in normal weight PWS. In conclusion, patients with PWS sho
w clear reduction of IGF-I levels as well as of the somatotroph responsiven
ess to provocative stimuli independently of body weight excess. These resul
ts strengthen the hypothesis that PWS syndrome is frequently connoted by GH
insufficiency. (J. Endocrinol. Invest. 23: 84-89, 2000) (C)2000, Editrice
Kurtis.